Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G for Tango Therapeutics, Inc. Common Stock (TNGX).
- Disclosed ownership: 5%.
- Date of event: 30 Jun 2025.
BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G Report for Tango Therapeutics, Inc. Common Stock (TNGX)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Symbol
- TNGX
- Shares outstanding
- 109,140,600 shares
- Disclosed Ownership
- 5,457,030 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Jul 2025, 20:12:41 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 21 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 5% ownership in Tango Therapeutics, Inc. Common Stock (TNGX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Jul 2025, 20:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5% | 5,457,030 | 5,323,498 | 0 | Spencer Fleming | Managing Director |